SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vera Russmann, Joanna Goc, Katharina Boes, Tanja Ongerth, Josephine D. Salvamoser, Claudia Siegl, Heidrun Potschka, Minocycline fails to exert antiepileptogenic effects in a rat status epilepticus model, European Journal of Pharmacology, 2016, 771, 29

    CrossRef

  2. 2
    Anil Kumar, Arti Singh, Ekavali, A review on Alzheimer's disease pathophysiology and its management: an update, Pharmacological Reports, 2015, 67, 2, 195

    CrossRef

  3. 3
    Alex Dregan, Phil Chowienczyk, Martin C. Gulliford, Calogero Caruso, Are Inflammation and Related Therapy Associated with All-Cause Dementia in a Primary Care Population?, Journal of Alzheimer's Disease, 2015, 46, 4, 1039

    CrossRef

  4. 4
    Chong Chen, Xiaohong Li, Peilong Gao, Yue Tu, Mingliang Zhao, Jianwei Li, Sai Zhang, Haiqian Liang, Baicalin attenuates Alzheimer-like pathological changes and memory deficits induced by amyloid β1–42 protein, Metabolic Brain Disease, 2015, 30, 2, 537

    CrossRef

  5. 5
    Bevyn Jarrott, Spencer J. Williams, Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation, Neurochemical Research, 2015,

    CrossRef

  6. 6
    Huma Syed, Muhammad Ikram, Ahmed Yaqinuddin, Touqeer Ahmed, Cyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice, Molecular Medicine Reports, 2015,

    CrossRef

  7. 7
    Katie J. Herbst-Robinson, Li Liu, Michael James, Yuemang Yao, Sharon X. Xie, Kurt R. Brunden, Inflammatory Eicosanoids Increase Amyloid Precursor Protein Expression via Activation of Multiple Neuronal Receptors, Scientific Reports, 2015, 5, 18286

    CrossRef

  8. 8
    Sina Shadfar, Chul Ju Hwang, Mi-Sun Lim, Dong-Young Choi, Jin Tae Hong, Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents, Archives of Pharmacal Research, 2015, 38, 12, 2106

    CrossRef

  9. 9
    Michael T Heneka, Monica J Carson, Joseph El Khoury, Gary E Landreth, Frederic Brosseron, Douglas L Feinstein, Andreas H Jacobs, Tony Wyss-Coray, Javier Vitorica, Richard M Ransohoff, Karl Herrup, Sally A Frautschy, Bente Finsen, Guy C Brown, Alexei Verkhratsky, Koji Yamanaka, Jari Koistinaho, Eicke Latz, Annett Halle, Gabor C Petzold, Terrence Town, Dave Morgan, Mari L Shinohara, V Hugh Perry, Clive Holmes, Nicolas G Bazan, David J Brooks, Stéphane Hunot, Bertrand Joseph, Nikolaus Deigendesch, Olga Garaschuk, Erik Boddeke, Charles A Dinarello, John C Breitner, Greg M Cole, Douglas T Golenbock, Markus P Kummer, Neuroinflammation in Alzheimer's disease, The Lancet Neurology, 2015, 14, 4, 388

    CrossRef

  10. 10
    Atish Prakash, Jaspreet Kalra, Vasudevan Mani, Kalavathy Ramasamy, Abu Bakar Abdul Majeed, Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets, Expert Review of Neurotherapeutics, 2015, 15, 1, 53

    CrossRef

  11. 11
    Sharad Kumar Suthar, Manu Sharma, Recent Developments in Chimeric NSAIDs as Safer Anti-Inflammatory Agents, Medicinal Research Reviews, 2015, 35, 2
  12. 12
    Shivika Rai, Pradeep K. Kamat, Chandishwar Nath, Rakesh Shukla, Glial Activation and Synaptic Neurotoxicity in Alzheimer's disease: A Focus on Neuroinflammation, Pharmacologia, 2014, 5, 8, 286

    CrossRef

  13. 13
    Amy M Birch, Loukia Katsouri, Magdalena Sastre, Modulation of inflammation in transgenic models of Alzheimer’s disease, Journal of Neuroinflammation, 2014, 11, 1, 25

    CrossRef

  14. 14
    Inelia Morales, Leonardo Guzmán-Martínez, Cristóbal Cerda-Troncoso, Gonzalo A. Farías, Ricardo B. Maccioni, Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  15. 15
    Keimin Lee, Soo-Jeong Kim, Donghoon Kim, Su-Hyun Jo, Sung Joong Lee, Se-Young Choi, Prostaglandin modulates TLR3-induced cytokine expression in human astroglioma cells, Brain Research, 2014, 1589, 54

    CrossRef

  16. 16
    Paola Vitale, Maria Grazia Perrone, Paola Malerba, Antonio Lavecchia, Antonio Scilimati, Selective COX-1 inhibition as a target of theranostic novel diarylisoxazoles, European Journal of Medicinal Chemistry, 2014, 74, 606

    CrossRef

  17. 17
    Eiron Cudaback, Nikolas L. Jorstad, Yue Yang, Thomas J. Montine, C. Dirk Keene, Therapeutic implications of the prostaglandin pathway in Alzheimer's disease, Biochemical Pharmacology, 2014, 88, 4, 565

    CrossRef

  18. 18
    R. Anand, Kiran Dip Gill, Abbas Ali Mahdi, Therapeutics of Alzheimer's disease: Past, present and future, Neuropharmacology, 2014, 76, 27

    CrossRef

  19. 19
    Neurodegenerative Disease and Micronutrients, 2014,

    CrossRef

  20. 20
    Petra M Hermann, Deborah Park, Emily Beaulieu, Willem C Wildering, Evidence for inflammation-mediated memory dysfunction in gastropods: putative PLA2 and COX inhibitors abolish long-term memory failure induced by systemic immune challenges, BMC Neuroscience, 2013, 14, 1, 83

    CrossRef

  21. 21
    Stefan Prokop, Kelly R. Miller, Frank L. Heppner, Microglia actions in Alzheimer’s disease, Acta Neuropathologica, 2013, 126, 4, 461

    CrossRef

  22. 22
    Qin Zhihui, Modulating nitric oxide signaling in the CNS for Alzheimer’s disease therapy, Future Medicinal Chemistry, 2013, 5, 12, 1451

    CrossRef

  23. 23
    Rituraj Niranjan, Molecular Basis of Etiological Implications in Alzheimer’s Disease: Focus on Neuroinflammation, Molecular Neurobiology, 2013, 48, 3, 412

    CrossRef

  24. 24
    Zhi-Yuan Zhang, Rolf Daniels, Hermann J. Schluesener, Oridonin ameliorates neuropathological changes and behavioural deficits in a mouse model of cerebral amyloidosis, Journal of Cellular and Molecular Medicine, 2013, 17, 12
  25. 25
    Patrick L. McGeer, Edith G. McGeer, The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy, Acta Neuropathologica, 2013, 126, 4, 479

    CrossRef